Group and externally funded R&D

Omnicorp Research

Deep-technology research with two operating programmes: quantum and medical.

Held under Omnicorp Research (Ltd)

Programmes

Quantum · Medical

Funding

Group + external

IP route

Omnicorp IP (Holdings)

Division overview

Research sits directly under the PLC and is funded from a blend of group budget, grant income and external programme partners. Output is commercialised through licence into Omnicorp IP (Holdings), which keeps the value of discovery inside the group regardless of which division deploys it.

Investment case

01

Long horizon, ring-fenced

Research is capitalised separately from operating divisions so long-cycle programmes are never funded from short-cycle cash flow.

02

Licence, don't lose

Every result is assigned to Omnicorp IP (Holdings) and licensed back, creating a durable royalty layer inside the group.

03

External co-funding

Grant and partner funding extends the programme without diluting group equity.

Corporate entities

Structure

Operating

Omnicorp Quantum (Ltd)

Quantum R&D — computation, sensing and cryptography.

Operating

Omnicorp Medical (Ltd)

Medical R&D — diagnostics and applied clinical technology.